Aurora Cannabis (NASDAQ:ACB) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Aurora Cannabis (NASDAQ:ACB) released its earnings results on Wednesday. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.04), Zacks reports. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.

Aurora Cannabis Stock Down 4.4%

Shares of ACB opened at $5.88 on Wednesday. Aurora Cannabis has a 12 month low of $3.42 and a 12 month high of $7.20. The stock has a market cap of $330.51 million, a price-to-earnings ratio of 117.62 and a beta of 1.82. The company has a 50-day moving average price of $5.04 and a two-hundred day moving average price of $4.74. The company has a quick ratio of 1.60, a current ratio of 3.30 and a debt-to-equity ratio of 0.07.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. raised its holdings in Aurora Cannabis Inc. (NASDAQ:ACB) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 743,903 shares of the company’s stock after purchasing an additional 29,099 shares during the quarter. Goldman Sachs Group Inc. owned approximately 1.32% of Aurora Cannabis worth $3,266,000 as of its most recent SEC filing. Institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.